StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
No sell-side coverage available for SSNC yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-19 | $67.51 | $66.25 | -1.87% | 2.5M |
| 05-20 | $66.05 | $67.20 | +1.75% | 2.4M |
| 05-21 | $69.19 | $66.95 | -3.24% | 3.0M |
| 05-22 | $66.77 | $67.04 | +0.40% | 2.0M |
| 05-26 | $66.28 | $66.74 | +0.69% | 2.0M |
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Earnings (▲ beat / ▼ miss) and ex-dividend dates plotted on the price line. Educational — proximity does not establish causation.
SS&C Technologies provides software products and software-enabled services to a variety of customers primarily in financial services. Acquisitions are a large part of SS&C's history. SS&C GlobeOp provides fund administration services to alternative and traditional asset managers. In addition, SS&C provides portfolio accounting, portfolio management, trading, banking/lending, and other software to asset managers, banks, and financial advisors. SS&C's purchase of Intralinks makes it a leading player in virtual deal room solutions. With its 2018 purchase of DST Systems, SS&C gained a foothold in the healthcare industry with pharmacy health management solutions and medical claim administration services. In 2022, SS&C acquired robotic process automation software firm Blue Prism.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.65B | $6.27B | $4.62B | $3.05B |
Operating Income | $398.20M | $1.44B | $1.07B | $702.40M |
Net Income | $226.10M | $796.90M | $603.80M | $393.80M |
EPS (Diluted) | $0.91 | $3.15 | $2.39 | $1.55 |
Total Assets | $20.33B | $20.71B | $19.49B | $18.98B |
Total Liabilities | $13.43B | $13.77B | $12.50B | $11.97B |
Cash & Equivalents | $420.90M | $462.10M | $388.30M | $480.30M |
Free Cash Flow OCF − CapEx | $293.70M | $1.66B | $1.03B | $609.50M |
Shares Outstanding | 240.80M | 241.40M | 243.50M | 244.00M |